Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Inhalation on Intermediate Markers of Carcinogenesis in the Bronchial Epithelium
NCT00407264Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone propionate in bronchogenic carcinoma, sponsored by Amsterdam University Medical Center. Started Feb 2002; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
bronchogenic carcinoma
Beyond the preview
Go deeper on NCT00407264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407264.